,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome, Anemia, Fatigue, Nausea, Pyrexia, Decreased Platelets, Diarrhea, Decreased Lymphocyte, Headache, Cough, Edema Peripheral, Death."
1,KYPROLIS,warnings and precautions,"Cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, death, Acute Renal Failure, renal impairment, renal failure, death, Tumor Lysis Syndrome, TLS, uric acid levels, death, Pulmonary Toxicity, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, death, Pulmonary Hypertension, PAH, Grade 3 or greater, death, Dyspnea, severe dyspnea, life-threatening dyspnea, death, Hypertension, hypertensive crisis, hypertensive emergency, death, Venous Thrombosis, deep venous thrombosis, pulmonary embolism, Infusion Reactions, life-threatening reactions, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, Thrombocytopenia, platelet nadirs, thrombocytopenia, death, Hepatic Toxicity, Hepatic Failure, increased serum transaminases, death, Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome, TTP/HUS, death, Posterior Reversible Encephalopathy Syndrome, PRES, Reversible Posterior Leukoencephalopathy Syndrome, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances, hypertension, death, Embryo-fetal Toxicity, fetal harm."
2,MULTAQ,adverse reactions,"New or worsening heart failure, Liver Injury, Pulmonary toxicity, Hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, death, gastrointestinal disorders, QT prolongation, dyspeptic signs and symptoms, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis."
3,MULTAQ,boxed warnings,"Death, Stroke, Heart failure"
4,MULTAQ,warnings and precautions,"Cardiovascular death, arrhythmic death, heart failure, stroke, new onset heart failure, worsening heart failure, liver injury, acute liver failure, hepatocellular liver injury, pulmonary toxicity, interstitial lung disease, pneumonitis, pulmonary fibrosis, hypokalemia, hypomagnesemia, QT interval prolongation, renal impairment, renal failure, renal dysfunction, death."
5,JUBLIA,adverse reactions,"Ingrown toenails, ingrown toenail, Application site dermatitis, Application site vesicles, Application site pain, death"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, death, constipation, vomiting, increased transaminases, hypokalemia, rash, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis."
7,TEFLARO,warnings and precautions,"Serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, direct Coombs' test seroconversion, drug-induced hemolytic anemia, death."
8,DATSCAN,adverse reactions,"Hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"Hypersensitivity reactions, Skin erythema, Pruritis, Anaphylactic reaction, Hypersensitivity reaction"
10,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, death, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, elevated ALT, elevated AST, hyperglycemia, elevated lipase, elevated cholesterol, elevated creatine kinase, neutropenia, hepatitis B, hepatitis C, immune reconstitution syndrome, changes in serum creatinine"
11,TIVICAY,warnings and precautions,"Hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, death, Transaminase elevations, immune reconstitution syndrome, hepatitis B reactivation, hepatotoxicity, Fat redistribution, body fat accumulation, central obesity, dorsocervical fat enlargement, buffalo hump, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", Immune reconstitution syndrome, inflammatory response, opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, death, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Hyperkeratosis, Headache, Pyrexia, Arthralgia, Papilloma, Alopecia, Palmar-plantar erythrodysesthesia syndrome, Chills, Fatigue, Rash, Nausea, Vomiting, Diarrhea, Abdominal pain, Peripheral edema, Cough, Night sweats, Decreased appetite, Constipation, Myalgia, Back pain, Nasopharyngitis, Rash, Squamous cell carcinoma of the skin, Cough, Constipation, Urinary tract infection, Vision blurred, Transient blindness, Stomatitis, Pancreatitis, Asthenia, Cellulitis, Folliculitis, Paronychia, Rash pustular, Palmar-plantar erythrodysesthesia syndrome, Hyperhidrosis, Hypertension"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, cutaneous malignancies, non-cutaneous malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, death"
14,HORIZANT,adverse reactions,"Somnolence, sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase."
15,HORIZANT,warnings and precautions,"Driving impairment, Somnolence, Sedation, Dizziness, Suicidal thoughts, Suicidal behaviors, Lack of Interchangeability With Gabapentin, Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Tumorigenic Potential, Death"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, death, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, pneumonia, abdominal pain, atrial fibrillation, constipation, dyspnea, vomiting, decreased appetite, urinary tract infection, skin infections, sinusitis, peripheral edema, pyrexia, asthenia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, petechiae, laceration, anxiety, insomnia, hypertension, hyperuricemia, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, elevated uric acid levels, anaphylactic shock, urticaria, angioedema."
17,IMBRUVICA,warnings and precautions,"Hemorrhage, bleeding, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, infections, fatal infections, progressive multifocal leukoencephalopathy, cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"Liver function abnormalities, nausea, arthralgia, rash, death, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis/leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis/cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms/twitching/tightness/weakness, musculoskeletal pain/stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration/altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions."
19,ULORIC,warnings and precautions,"Gout Flare, Cardiovascular Events, Hepatic Effects, hepatic failure, liver injury, transaminase elevations, Cardiovascular thromboembolic events, Myocardial infarction (MI), Stroke, Fatal hepatic failure, Death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, death, tuberculosis infections, pyrexia, urticaria, pneumonia, abdominal pain, diarrhea, intestinal obstruction, Crohn's disease, rheumatoid arthritis, arthralgia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, vasculitis, thrombophlebitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, sarcoidosis."
21,CIMZIA,boxed warnings,"Serious infections, death, active tuberculosis, invasive fungal infections, death, bacterial infections, viral infections, other infections due to opportunistic pathogens, malignancy, lymphoma"
22,CIMZIA,warnings and precautions,"Serious infections, death, invasive fungal infections, lymphoma, heart failure, anaphylaxis, allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, central nervous system demyelinating disease, peripheral demyelinating disease, hematological reactions, pancytopenia, aplastic anemia, autoimmune reactions, lupus-like syndrome."
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, increased hepatic enzymes, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, aspartate aminotransferase increased, blood glucose increased, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne."
24,KALYDECO,warnings and precautions,"Elevated transaminases, liver function abnormalities, Cataracts, Death"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count."
26,FULYZAQ,warnings and precautions,"Diarrhea, Infectious etiologies, Non-infectious diarrhea, Disease worsening"
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, Application site erythema, Application site pain, Application site pruritus, Application site papules, Application site edema, Application site swelling, Application site dryness, Nasopharyngitis, Bronchitis, Sinusitis, Nausea, Vomiting, Pruritus, Hypertension, Application site urticaria, Application site paresthesia, Application site dermatitis, Application site hyperesthesia, Application site excoriation, Application site warmth, Application site anesthesia, Application site bruising, Application site inflammation, Application site exfoliation, Peripheral edema, Headache, Burning sensation, Peripheral sensory neuropathy, Dizziness, Dysgeusia, Hyperesthesia, Hypoesthesia, Cough, Throat irritation, Abnormal skin odor"
28,QUTENZA,warnings and precautions,"Eye irritation, Mucous membrane irritation, Coughing, Sneezing, Skin irritation, Transient increases in blood pressure, Pain, Increase in blood pressure, Death."
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, Bone pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), Cutaneous vasculitis, Thrombocytopenia, Death."
30,GRANIX,warnings and precautions,"Splenic rupture, death, Acute Respiratory Distress Syndrome (ARDS), Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, death, Sickle cell crisis, death, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells"
31,COARTEM,adverse reactions,"Headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, headache, death"
32,COARTEM,warnings and precautions,"QT prolongation, prolongation of the QT interval, long QT syndrome, sudden death, hypokalemia, hypomagnesemia, electrolyte imbalance, cardiac arrhythmias, bradycardia, severe cardiac disease, disturbances of electrolyte balance, class IA antiarrhythmic agents, class III antiarrhythmic agents, antipsychotics, antidepressants, macrolide antibiotics, fluoroquinolone antibiotics, imidazole antifungal agents, triazole antifungal agents, medications metabolized by CYP2D6, cardiac effects, ECG monitoring, decreased exposure to lumefantrine, decreased efficacy, drug interactions with CYP3A4, substrates of CYP3A4, inhibitors of CYP3A4, inducers of CYP3A4, grapefruit juice, antiretroviral drugs, HIV protease inhibitors, non-nucleoside reverse transcriptase inhibitors, hormonal contraceptives, plasma concentrations, adverse effects, recrudescence, recrudescent P. falciparum infection, hepatic impairment, renal impairment, Plasmodium vivax infection."
33,APTIOM,adverse reactions,"Suicidal Behavior, Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, death"
34,APTIOM,warnings and precautions,"suicidal behavior, suicidal ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, death"
35,PROLIA,adverse reactions,"Hypocalcemia, death, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, pancreatitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, vertigo, erysipelas, cellulitis, epidermal adverse events, dermal adverse events, ONJ (Osteonecrosis of the Jaw), atypical femoral fractures, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, marked elevation in serum PTH, immunogenicity."
36,PROLIA,warnings and precautions,"Hypersensitivity, anaphylactic reactions, death, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, musculoskeletal pain, bone, joint, muscle pain, suppression of bone turnover"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, death, Neurological Toxicities, Infections, death, Tumor Lysis Syndrome, Neutropenia, death, Febrile Neutropenia, death, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, Pyrexia, Headache, Peripheral Edema, Nausea, Hypokalemia, Tremor, Rash, Constipation, Febrile Neutropenia, death, Pneumonia, death, Sepsis, death, Device-related infection, Encephalopathy, death, Infection, death, Overdose, Confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypokalemia, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Rash, Hypotension, Hypertension, Leukocytosis, Lymphopenia, Tachycardia, Edema, Cytokine storm, Decreased immunoglobulins, Increased blood bilirubin, Increased gamma-glutamyl-transferase, Increased liver enzymes, Tumor lysis syndrome, Hypoalbuminemia, Encephalopathy, death, Paresthesia, Aphasia, Convulsion, Memory impairment, Cognitive disorder, Speech disorder, Confusion, Disorientation, Capillary leak syndrome, Hypersensitivity, Bronchospasm"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome (CRS), death, Neurological toxicities, death"
39,BLINCYTO,warnings and precautions,"Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, death, Cytokine Release Syndrome (CRS), pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), death, Neurological Toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion, disorientation, coordination and balance disorders, death, Serious Infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, death, Tumor Lysis Syndrome (TLS), death, Neutropenia, febrile neutropenia, death, Elevated Liver Enzymes, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), total blood bilirubin, death, Leukoencephalopathy, Preparation and Administration Errors."
40,STENDRA,adverse reactions,"Headache, death, Flushing, Nasal congestion, Nasopharyngitis, Back pain, Upper respiratory infection (URI), Bronchitis, Influenza, Sinusitis, Sinus congestion, Hypertension, Dyspepsia, Nausea, Constipation, Rash, Dizziness, Arthralgia, Diarrhea, Edema peripheral, Fatigue, Angina, Unstable angina, Deep vein thrombosis, Palpitations, Gastritis, Gastroesophageal reflux disease, Hypoglycemia, Increased blood glucose, Increased alanine aminotransferase, Oropharyngeal pain, Stomach discomfort, Vomiting, Muscle spasms, Musculoskeletal pain, Myalgia, Pain in extremity, Depression, Insomnia, Somnolence, Vertigo, Cough, Dyspnea exertional, Epistaxis, Wheezing, Pruritus, Balanitis, Erection increased, Hematuria, Nephrolithiasis, Pollakiuria, Urinary tract infection, Electrocardiogram abnormal, Gastroenteritis viral, Change in color vision."
41,STENDRA,warnings and precautions,"hypotension, erection lasting greater than 4 hours, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, prolonged erection, priapism, anatomical deformation of the penis, penile tissue damage, permanent loss of potency, sudden loss of vision in one or both eyes, non-arteritic anterior ischemic optic neuropathy (NAION), sudden decrease or loss of hearing, dizziness, lightheadedness, fainting, symptomatic hypotension, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, headache, bleeding disorders, active peptic ulceration, sexually transmitted diseases, death"
42,XIAFLEX,adverse reactions,"Tendon ruptures, serious injury, flexor tendon rupture, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, penile hematoma, penile ecchymoses, penile hemorrhage, penile bruising, injection site bruising, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, pruritus, finger extension procedures, vasovagal syncope, laceration, blood blister, injection site pain, injection site inflammation, injection site irritation, injection site warmth, injection site swelling, injection site edema, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, penile detumescence, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, nodule, suprapubic pain, penile ""popping"" sounds or sensations, Death (if a fatal event is listed)"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, penile injury, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation"
44,XIAFLEX,warnings and precautions,"Tendon rupture, serious injury, ligament damage, skin laceration, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality, penile fracture, penile detumescence, penile popping, penile hematoma, severe penile hematoma, hypersensitivity reactions, anaphylaxis, pruritus, allergic reactions, ecchymoses, corporal rupture, bleeding, injection site hemorrhage, penile ecchymosis."
45,XEOMIN,adverse reactions,"Hypersensitivity, death, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, eye disorders, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, facial pain, muscle disorder, elevation of eyebrow, eye swelling, nausea, flu-like symptoms, allergic dermatitis, localized allergic reactions like swelling, edema, erythema, pruritus or rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia."
46,XEOMIN,boxed warnings,"Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphagia, Dysphonia, Dysarthria, Urinary incontinence, Breathing difficulties, Death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, dysphagia, dysphonia, dysarthria, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, urinary incontinence, breathing difficulties, death, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, diplopia, ecchymosis, ptosis, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, cervical dystonia, neuromuscular disorders, respiratory compromise, ectropion, narrow angle glaucoma, viral diseases, Creutzfeldt-Jakob disease"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous and Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, death, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, dyspnea, fatigue, hypokalemia, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, stomatitis, aphthous stomatitis, mucosal inflammation, mouth ulceration, oral mucosa erosion, mucosal erosion, mucosal ulceration, acne, acne pustular, dermatitis acneiform, paronychia, nail infection, nail bed infection, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis."
49,GILOTRIF,warnings and precautions,"Diarrhea, dehydration, renal failure, death, Bullous skin disorders, exfoliative skin disorders, bullous lesions, blistering lesions, exfoliating lesions, cutaneous reactions, rash, erythema, acneiform rash, palmar-plantar erythrodysesthesia syndrome, Interstitial lung disease, ILD, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, fatal event, death, Hepatic toxicity, hepatic impairment, liver test abnormalities, fatal event, death, Keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, Embryofetal toxicity, fetal harm."
50,TREANDA,adverse reactions,"Myelosuppression, Infections, Anaphylaxis, Infusion Reactions, Tumor Lysis Syndrome, Skin Reactions, Other Malignancies, Extravasation injury, Pyrexia, Nausea, Vomiting, Asthenia, Fatigue, Malaise, Weakness, Dry mouth, Somnolence, Cough, Constipation, Headache, Mucosal inflammation, Stomatitis, Worsening hypertension, Hypertensive crisis, Hypersensitivity, Bilirubin elevations, AST elevation, ALT elevation, Creatinine level changes, Death, Febrile neutropenia, Pneumonia, Hypokalemia, Dehydration, Tachycardia, Abdominal pain, Dyspepsia, Gastroesophageal reflux disease, Abdominal distension, Edema peripheral, Chest pain, Infusion site pain, Pain, Catheter site pain, Herpes zoster, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Oral candidiasis, Nasopharyngitis, Weight decreased, Anorexia, Decreased appetite, Hyperuricemia, Back pain, Arthralgia, Pain in extremity, Bone pain, Headache, Dizziness, Dysgeusia, Insomnia, Anxiety, Depression, Pharyngolaryngeal pain, Wheezing, Nasal congestion, Dry skin, Night sweats, Hyperhidrosis, Hypotension, Rash, Pruritus, Hypoglycemia, Elevated creatinine, Hyponatremia, Hypocalcemia, Acute renal failure, Cardiac failure, Skin reactions, Pulmonary fibrosis, Myelodysplastic syndrome, Hemolysis, Taste disorder, Atypical pneumonia, Sepsis, Herpes zoster, Erythema, Dermatitis, Skin necrosis, Anaphylaxis, Phlebitis, Injection site reactions, Pneumocystis jiroveci pneumonia, Pneumonitis, Stevens-Johnson syndrome, Toxic epidermal necrolysis."
51,TREANDA,warnings and precautions,"Myelosuppression, death, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, acute renal failure, skin reactions, SJS, TEN, fatal, other malignancies, extravasation, embryo-fetal toxicity"
52,CHOLINE,adverse reactions,"injection site reaction, death"
53,CHOLINE,warnings and precautions,"Imaging errors, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging due to concomitant use of colchicine or androgen-deprivation therapeutic drugs, allergic reactions, anaphylaxis, radiation exposure, increased risk for cancer, death."
54,ERWINAZE,adverse reactions,"Hypersensitivity reactions, death, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea"
55,ERWINAZE,warnings and precautions,"Serious hypersensitivity reactions, anaphylaxis, Severe pancreatitis, hemorrhagic pancreatitis, Glucose intolerance, Thrombosis, hemorrhage, death"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, death, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide, GLP-1, hypersensitivity, urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase."
57,TRULICITY,boxed warnings,"Thyroid C-cell tumors, Medullary thyroid carcinoma (MTC), Mass in the neck, Dysphagia, Dyspnea, Persistent hoarseness, Death"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, death, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease"
59,ADREVIEW,adverse reactions,"dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, serious reactions, imaging errors, withdrawal signs and symptoms, benzyl alcohol toxicity, Gasping Syndrome, toxicity, kernicterus, death, increased radiation exposure, decreased quality of images, thyroid accumulation, increased risk for thyroid neoplasia, hypertension"
61,DOTAREM,adverse reactions,"NSF, Hypersensitivity reactions, Acute kidney injury, Nausea, Headache, Injection site pain, Injection site coldness, Burning sensation, Feeling cold, Rash, Somnolence, Fatigue, Dizziness, Vomiting, Pruritus, Paresthesia, Dysgeusia, Pain in extremity, Anxiety, Hypertension, Palpitations, Oropharyngeal discomfort, Serum creatinine increased, Injection site reactions (including site inflammation, extravasation, pruritus, warmth), Bradycardia, Tachycardia, Arrhythmia, Anaphylactoid reactions, Cardiac arrest, Respiratory arrest, Cyanosis, Pharyngeal edema, Laryngospasm, Bronchospasm, Angioedema, Conjunctivitis, Ocular hyperemia, Eyelid edema, Lacrimation increased, Hyperhidrosis, Urticaria, Coma, Convulsion, Syncope, Presyncope, Parosmia, Tremor, Muscle contracture, Muscle weakness, Diarrhea, Salivary hypersecretion, Malaise, Fever, NSF, Superficial phlebitis, Death."
62,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis, NSF, fatal event, death, fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, chronic kidney disease, severe kidney disease, acute kidney injury, impaired elimination, gadolinium-based contrast agents, GBCAs, renal function, glomerular filtration rate, DOTAREM dose."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal events, dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, other intracranial bleeding, fatal bleeding, non-intracranial fatal bleeding, any gastrointestinal bleeds, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"THROMBOTIC EVENTS, SPINAL/EPIDURAL HEMATOMA, DEATH"
66,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, blood loss, hemorrhage, thrombotic events, significant bleeding, spinal or epidural hematoma, paralysis, major bleeding, neurological impairment, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, P-gp inducers and inhibitors, increased exposure to dabigatran"
67,ELIQUIS,adverse reactions,"Thrombotic events, bleeding, spinal/epidural anesthesia or puncture, death, major bleeding, intracranial bleed, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, drug hypersensitivity, skin rash, anaphylactic reactions, allergic edema, syncope, nausea, anemia, contusion, hematoma, postprocedural hemorrhage, transaminases increased, alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, menorrhagia, major bleeding, clinically relevant nonmajor bleeding, minor bleeding, blood urine present, occult blood positive, red blood cells urine positive, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, injection-site hematoma, vessel puncture-site hematoma."
68,ELIQUIS,boxed warnings,"Thrombotic events, Spinal/epidural hematoma, Paralysis, Neurological impairment, Death"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, blood loss, stroke, bleeding, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, paralysis, neurological impairment, numbness, weakness, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, Nausea, Diarrhea, Headache, Pyrexia, Constipation, Insomnia, Vomiting, Hypokalemia, ALT increased, AST increased, Anemia, Thrombocytosis, Abdominal pain, Anxiety, Dizziness, Hypotension, Atrial fibrillation, Rash, Renal impairment, Renal failure, Renal failure acute, Tachycardia, Angina pectoris, Ileus, Gastritis, Abdominal distension, Dyspepsia, Flatulence, Ileus paralytic, Infusion site reactions, Candidiasis, Oropharyngeal fungal urinary tract infection, Increased serum gamma-glutamyl transpeptidase (GGT), Increased serum alkaline phosphatase, Positive Coombs test, Hyperglycemia, Hypomagnesemia, Hypophosphatemia, Ischemic stroke, Dyspnea, Urticaria, Venous thrombosis, Death"
71,ZERBAXA,warnings and precautions,"Decreased efficacy, hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, diarrhea, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death."
73,FERRIPROX,boxed warnings,"Agranulocytosis, Neutropenia, Serious infections, Death"
74,FERRIPROX,warnings and precautions,"Agranulocytosis, Neutropenia, death, Embryofetal Toxicity"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, death"
76,DALVANCE,warnings and precautions,"Hypersensitivity reactions, anaphylactic reactions, skin reactions, ALT elevations, Clostridium difficile-associated diarrhea, death"
77,ARCAPTA,adverse reactions,"asthma-related death, death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia/heart rate increase/palpitations, pruritus/rash, dizziness"
78,ARCAPTA,boxed warnings,"asthma-related death, death, asthma-related deaths, fatal event, LABA, long-acting beta 2-adrenergic agonists, salmeterol, indacaterol, ARCAPTA NEOHALER"
79,ARCAPTA,warnings and precautions,"asthma-related death, death, immediate hypersensitivity reactions, life-threatening paradoxical bronchospasm, paradoxical bronchospasm, cardiovascular effects, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"Fatigue, Headache, Nausea, Diarrhea, Back pain, Pain in extremities, Upper abdominal pain, Arthralgia, Migraine, Flatulence, Oropharyngeal pain, Dizziness, Asthenia, Cough, Dyspepsia, Gastroesophageal reflux disease, Constipation, Palpitations, Rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, Prolongation of PR interval, Prolongation of QTc interval, Prolongation of QRS interval"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis, death, Hypersensitivity reactions, death, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, increased blood pressure, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor."
83,GADAVIST,boxed warnings,"Nephrogenic systemic fibrosis, death, chronic kidney disease, severe kidney disease, acute kidney injury, impaired elimination of drugs, reduced renal function, hypertension, diabetes"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute Kidney Injury, Extravasation, Injection Site Reactions, Overestimation of Extent of Malignant Disease"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Diarrhea, Nausea, Elevated transaminases, Vomiting, Abdominal pain, Fatigue, Decreased appetite, Constipation, Convulsion, Pneumonia, Dyspnea, Dehydration, Fatal event: Death, ILD/pneumonitis, Hyperglycemia, Increased ALT, Increased AST, Serious adverse drug reactions, Respiratory failure, Pneumothorax, Gastric hemorrhage, General physical health deterioration, Pulmonary tuberculosis, Cardiac tamponade, Sepsis, Discontinuation of therapy, Rash, Neuropathy, Vision disorder, Prolonged QT interval, Hemoglobin decreased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin increased."
86,ZYKADIA,warnings and precautions,"Severe or Persistent Gastrointestinal Toxicity, diarrhea, nausea, vomiting, abdominal pain, Hepatotoxicity, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, death, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity"
87,XALKORI,adverse reactions,"Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, death, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, ILD, renal cyst, neuropathy, rash, syncope, weight increased, pain in extremity, muscle spasm, dizziness, headache, weight decreased, ALT elevation, AST elevation, hypophosphatemia, neutropenia, lymphopenia, hypokalemia."
88,XALKORI,warnings and precautions,"Hepatotoxicity, liver toxicity, elevated transaminases, elevated liver enzymes, hepatotoxicity-related death, Interstitial Lung Disease (ILD), pneumonitis, fatal ILD, life-threatening ILD, severe ILD, interstitial lung disease-related death, QT Interval Prolongation, prolonged QT interval, QTc prolongation, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, QT prolongation-related death, Bradycardia, slow heart rate, symptomatic bradycardia, life-threatening bradycardia, heart rate less than 50 bpm, Grade 3 syncope, Severe Visual Loss, vision loss, visual field defect, optic atrophy, optic nerve disorder, severe visual loss-related death, Embryofetal Toxicity, fetal harm, embryotoxicity, fetotoxicity."
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, itching, body rash, swelling of lips, swelling of tongue, swelling of throat, death"
90,BEPREVE,warnings and precautions,"Contamination, Irritation, Redness, Absorption, Death"
91,EDARBI,adverse reactions,"Diarrhea, death, Hypotension/orthostatic hypotension, Nausea, Asthenia, fatigue, Muscle spasm, Dizziness, dizziness postural, Cough, Rash, Pruritus, Angioedema"
92,EDARBI,boxed warnings,"Fetal toxicity, Injury to the developing fetus, Death"
93,EDARBI,warnings and precautions,"death, fetal renal function reduction, fetal and neonatal morbidity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, changes in renal function, oliguria, progressive azotemia, acute renal failure"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, death, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, dizziness, somnolence, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, confusional state, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, urinary retention, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy."
95,POTIGA,boxed warnings,"Retinal abnormalities, vision loss, abnormal visual acuity, retinal pigmentary abnormalities, vision changes, death"
96,POTIGA,warnings and precautions,"Urinary retention, skin discoloration, retinal abnormalities, vision loss, neuropsychiatric symptoms, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behavior, death."
97,TUDORZA,adverse reactions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate Hypersensitivity Reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"Paradoxical bronchospasm, Worsening of narrow-angle glaucoma, Worsening of urinary retention, Immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, death"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, Nausea, Diarrhea, Upper respiratory tract infection, Vomiting, Increased ALT, Myalgia, Urinary tract infection, Anemia, Pyrexia, Fatigue, Headache, Decreased appetite, Influenza-like illness, Asthenia, Insomnia, Cough, Pruritus, Chills, Alopecia, Peripheral edema, Hemorrhage, Thrombotic/thromboembolic complications, Oropharyngeal pain, Increased AST, Pharyngitis, Back pain, Paresthesia, Rash, Alopecia, Musculoskeletal pain, Blood alkaline phosphatase increased, Dry mouth, Hyperbilirubinemia, ALT increased, Cataract, Toothache, Vitamin D deficiency, Abdominal pain, AST increased, Thrombotic microangiopathy with acute renal failure, Death."
100,PROMACTA,boxed warnings,Hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, liver enzyme elevations, hepatic decompensation, ascites, encephalopathy, indirect hyperbilirubinemia, abnormal serum liver tests, liver injury, thrombotic event, thrombotic/thromboembolic complications, venous events, arterial events, portal venous system events, thrombotic complications, portal vein thrombosis, abdominal pain, nausea, vomiting, diarrhea, cataracts"
102,INLYTA,adverse reactions,"Diarrhea, Hypertension, Fatigue, Decreased appetite, Nausea, Dysphonia, Palmar-plantar erythrodysesthesia syndrome, Weight decreased, Vomiting, Asthenia, Constipation, Hypothyroidism, Cough, Mucosal inflammation, Arthralgia, Stomatitis, Dyspnea, Abdominal pain, Headache, Pain in extremity, Rash, Proteinuria, Dysgeusia, Dry skin, Dyspepsia, Pruritus, Alopecia, Erythema, Dizziness, Upper abdominal pain, Myalgia, Dehydration, Epistaxis, Anemia, Hemorrhoids, Hematuria, Tinnitus, Lipase increased, Glossodynia, Pulmonary embolism, Rectal hemorrhage, Hemoptysis, Deep vein thrombosis, Retinal-vein occlusion/thrombosis, Polycythemia, Transient ischemic attack, Hemoglobin decreased, Lymphocytes (absolute) decreased, Platelets decreased, White blood cells decreased, Creatinine increased, Bicarbonate decreased, Hypocalcemia, ALP increased, Hyperglycemia, Lipase increased, Amylase increased, ALT increased, AST increased, Hypernatremia, Hypoalbuminemia, Hyperkalemia, Hypoglycemia, Hyponatremia, Hypophosphatemia, Hemoglobin increased, Hypercalcemia, Death"
103,INLYTA,warnings and precautions,"Hypertension, hypertensive crisis, Arterial thrombotic events, arterial thromboembolic events, cerebrovascular accident, myocardial infarction, retinal artery occlusion, death, Venous thromboembolic events, pulmonary embolism, deep vein thrombosis, retinal vein occlusion, retinal vein thrombosis, death, Hemorrhagic events, cerebral hemorrhage, hematuria, hemoptysis, lower gastrointestinal hemorrhage, melena, gastric hemorrhage, death, Cardiac failure, death, Gastrointestinal perforation, fistula formation, death, Hypothyroidism, hyperthyroidism, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), Proteinuria, Elevation of liver enzymes, Hepatic impairment, Pregnancy"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, Headache, dizziness, nausea, hypertension, fatigue, death, increased blood pressure, falls, urinary tract infections, syncope."
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"Supine hypertension, cardiovascular events, hyperpyrexia, confusion, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, ischemic heart disease exacerbation, arrhythmias exacerbation, congestive heart failure exacerbation, allergic reactions, bronchial asthma, death"
107,JARDIANCE,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Urinary Tract Infections, Increased Low-Density Lipoprotein Cholesterol (LDL-C), Urinary tract infection, asymptomatic bacteriuria, cystitis, Female genital mycotic infections, vulvovaginal mycotic infection, vaginal infection, vulvitis, vulvovaginal candidiasis, genital infection, genital candidiasis, genital infection fungal, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial, Male genital mycotic infections, balanoposthitis, balanitis, genital infections fungal, genitourinary tract infection, balanitis candida, scrotal abscess, penile infection, Upper respiratory tract infection, Increased urination, polyuria, pollakiuria, nocturia, Dyslipidemia, Arthralgia, Nausea, Thirst, polydipsia, Volume Depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, Increase in Hematocrit"
108,JARDIANCE,warnings and precautions,"Hypotension, death, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Urinary tract infections, Increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, death"
110,FANAPT,boxed warnings,"Increased mortality, Death, Cardiovascular events (e.g., heart failure, sudden death), Infectious events (e.g., pneumonia)"
111,FANAPT,warnings and precautions,"Death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight gain, Seizures, Orthostatic hypotension, dizziness, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, Cognitive and motor impairment"
112,TANZEUM,adverse reactions,"Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Insulin Secretagogues, Insulin, Hypersensitivity Reactions, Renal Impairment, death, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, vomiting, gastroesophageal reflux disease, dyspepsia, Constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, Atrial Fibrillation, Atrial Flutter, Appendicitis, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"Thyroid C-cell tumors, medullary thyroid carcinoma, death"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, death"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, death."
116,EYLEA,warnings and precautions,"Endophthalmitis, Retinal detachments, Increases in intraocular pressure, Arterial thromboembolic events, Nonfatal stroke, Nonfatal myocardial infarction, Vascular death, Death."
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Death, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Infections (fatal), Renal Failure (fatal), Ventricular Fibrillation (fatal), Cerebral Hemorrhage (fatal), Dyspnea (fatal), Arrhythmia, Febrile Neutropenia, Mucosal Inflammation, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Gastritis, Intestinal Obstruction."
118,JEVTANA,boxed warnings,"Neutropenia, Death, Hypersensitivity, Generalized rash, Erythema, Hypotension, Bronchospasm"
119,JEVTANA,warnings and precautions,"Bone marrow suppression, neutropenia, anemia, thrombocytopenia, pancytopenia, febrile neutropenia, neutropenic infections, sepsis, septic shock, infectious adverse events, neutropenic deaths, fatal infectious adverse events, grade 4 neutropenia, grade 3-4 neutropenia, Hypersensitivity reactions, severe hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, Gastrointestinal disorders, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, death, Renal failure, fatal outcomes, Elderly patients, fatal outcomes not related to disease progression, certain adverse reactions, neutropenia, febrile neutropenia, Hepatic impairment, Embryo-Fetal Toxicity, fetal harm."
120,YERVOY,adverse reactions,"Immune-mediated enterocolitis, Immune-mediated hepatitis, Immune-mediated dermatitis, Immune-mediated neuropathies, Immune-mediated endocrinopathies, Other immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, death, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)."
121,YERVOY,boxed warnings,"Enterocolitis, Hepatitis, Dermatitis (including toxic epidermal necrolysis), Neuropathy, Endocrinopathy, Death"
122,YERVOY,warnings and precautions,"Immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, intestinal perforation, death, immune-mediated hepatitis, hepatotoxicity, hepatic failure, hospitalization, death, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash, dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, death, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, death, immune-mediated endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hospitalization, death, other immune-mediated adverse reactions, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, myositis, polymyositis, ocular myositis, death."
123,FARXIGA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hypoglycemia, death, Genital Mycotic Infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Female genital mycotic infections, vulvovaginal mycotic infection, vaginal infection, vulvovaginal candidiasis, vulvovaginitis, genital infection, genital candidiasis, fungal genital infection, vulvitis, genitourinary tract infection, vulval abscess, vaginitis bacterial, Nasopharyngitis, Urinary tract infections, urinary tract infection, cystitis, Escherichia urinary tract infection, genitourinary tract infection, pyelonephritis, trigonitis, urethritis, kidney infection, prostatitis, Back pain, Increased urination, pollakiuria, polyuria, urine output increased, Male genital mycotic infections, balanitis, fungal genital infection, balanitis candida, genital candidiasis, genital infection male, penile infection, balanoposthitis, balanoposthitis infective, posthitis, Nausea, Influenza, Dyslipidemia, Constipation, Discomfort with urination, Pain in extremity, Volume Depletion, dehydration, hypovolemia, orthostatic hypotension, Renal-related adverse reactions, renal failure, blood creatinine increase, Bone fractures, Hypersensitivity reactions, angioedema, urticaria, hypersensitivity, Increase in Hematocrit, Increase in Serum Inorganic Phosphorus, Increase in Low-Density Lipoprotein Cholesterol."
124,FARXIGA,warnings and precautions,"Hypotension, Impairment in renal function, Hypoglycemia, Genital mycotic infections, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), Bladder Cancer, Death"
125,PICATO,adverse reactions,"local skin reactions, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, death"
126,PICATO,warnings and precautions,"Eye disorders, Severe eye pain, Chemical conjunctivitis, Corneal burn, Eyelid edema, Eyelid ptosis, Periorbital edema, Local skin reactions, Severe reactions, Vesiculation, Pustulation, Erosion, Ulceration, Hypersensitivity reactions, Anaphylaxis, Allergic contact dermatitis, Severe skin reactions, Erythema, Crusting, Swelling, Vesiculation, Postulation, Erosion, Ulceration"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, vomiting, headache, chills, feeling jittery, tremor, disturbance in attention, abnormal dreams, urinary hesitation, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions (including myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization), tachycardia, proteinuria, vital sign changes, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome, death."
128,PRISTIQ,boxed warnings,"Suicidal thoughts, Suicidal behaviors, Risk of suicidal thinking, Risk of suicidal behavior, Worsening of suicidal thoughts, Emergence of suicidal thoughts, Emergence of suicidal behaviors, Death"
129,PRISTIQ,warnings and precautions,"suicidal thoughts, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, proteinuria, asthenia, allergic reaction, angioedema, lactic acidosis, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rash, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, polyuria, death."
131,STRIBILD,boxed warnings,"Lactic acidosis, Severe hepatomegaly with steatosis, Fatal cases (associated with lactic acidosis and severe hepatomegaly with steatosis), Post treatment acute exacerbation of hepatitis B, Death"
132,STRIBILD,warnings and precautions,"Lactic acidosis, Severe hepatomegaly with steatosis, Renal impairment, Acute renal failure, Fanconi syndrome, Loss of virologic response, Drug interactions, Decreases in bone mineral density, Redistribution/accumulation of body fat, Immune reconstitution syndrome, Death"
133,NULOJIX,adverse reactions,"Post-Transplant Lymphoproliferative Disorder (PTLD), CNS PTLD, Non-CNS PTLD, EBV seropositive, EBV seronegative, CNS involvement, death, Progressive Multifocal Leukoencephalopathy (PML), fatal event, death, Bacterial infections, Mycobacterial infections, Viral infections, Fungal infections, Cryptococcal meningitis, Infusion reactions, Proteinuria, New-Onset Diabetes After Transplantation (NODAT), Hypertension, Dyslipidemia, Anemia, Diarrhea, Urinary tract infection, Peripheral edema, Constipation, Hypertension, Pyrexia, Graft dysfunction, Cough, Nausea, Vomiting, Headache, Hypokalemia, Hyperkalemia, Leukopenia"
134,NULOJIX,boxed warnings,"Post-transplant lymphoproliferative disorder, Other malignancies, Serious infections, Increased risk for developing post-transplant lymphoproliferative disorder, Increased risk for developing malignancies, Increased susceptibility to infection, Possible development of malignancies, Increased risk of graft loss, Death."
135,NULOJIX,warnings and precautions,"PTLD, CNS involvement, Neurological signs and symptoms, Cognitive signs and symptoms, Behavioral signs and symptoms, Other malignancies, Skin malignancies, UV light exposure, PML, Bacterial infections, Viral infections, Fungal infections, Protozoal infections, Opportunistic infections, Tuberculosis, Polyoma virus-associated nephropathy, Kidney graft loss, Liver transplant (not recommended), Acute rejection, Graft loss, Corticosteroid minimization, Immunizations with live vaccines, Death"
136,LUMIZYME,adverse reactions,"Hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, death, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, chest pain/discomfort, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, rash papular, edema, peripheral, throat tightness, delayed-onset reactions, hyperparathyroidism, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions."
137,LUMIZYME,boxed warnings,"Anaphylaxis, hypersensitivity reactions, immune-mediated reactions, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, death."
138,LUMIZYME,warnings and precautions,"Anaphylaxis, Hypersensitivity reactions, Life-threatening reactions, Anaphylactic shock, Cardiac arrest, Respiratory arrest, Respiratory distress, Hypoxia, Apnea, Dyspnea, Bradycardia, Tachycardia, Bronchospasm, Throat tightness, Hypotension, Angioedema, Tongue swelling, Lip swelling, Periorbital edema, Face edema, Urticaria, Chest discomfort, Chest pain, Wheezing, Tachypnea, Cyanosis, Decreased oxygen saturation, Convulsions, Pruritus, Rash, Hyperhidrosis, Nausea, Dizziness, Hypertension, Increased blood pressure, Flushing, Feeling hot, Erythema, Pyrexia, Pallor, Peripheral coldness, Restlessness, Nervousness, Headache, Back pain, Paresthesia, Immune-mediated reactions, Cutaneous reactions, Necrotizing skin lesions, Systemic immune-mediated reactions, Type III immune-mediated reactions, Inflammatory arthropathy, Pyrexia, Elevated erythrocyte sedimentation rate, Nephrotic syndrome, Membranous glomerulonephritis, Acute cardiorespiratory failure, Cardiac arrhythmia, Sudden cardiac death, Ventricular arrhythmias, Bradycardia, Cardiac arrest, Antibody development, Immunogenicity, IgG antibodies, Reduced clinical efficacy, Loss of motor function, Ventilator dependence, Death, Inhibitory antibody activity, IgE antibodies, Antibody testing."
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis, death, Hypersensitivity reactions, death, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, Nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, restlessness"
140,EOVIST,boxed warnings,"NEPHROGENIC SYSTEMIC FIBROSIS (NSF), death"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, death, Hypersensitivity, Anaphylactoid reactions, Cardiovascular reactions, Respiratory reactions, Cutaneous reactions, Shock, Acute Kidney Injury, Extravasation, Injection Site Reactions, Interference with Laboratory Tests, Interference with Visualization of Liver Lesions"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, death"
143,BELEODAQ,warnings and precautions,"Thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, death, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality."
144,VICTRELIS,adverse reactions,"Fatigue, Anemia, Nausea, Headache, Dysgeusia, Neutropenia, Pancytopenia, Hypersensitivity, Death (for fatal events), Dry mouth, Diarrhea, Vomiting, Decreased appetite, Arthralgia, Dizziness, Insomnia, Irritability, Dyspnea exertional, Alopecia, Dry skin, Rash, Chills, Asthenia, Decreased hemoglobin, Decreased neutrophils, Decreased platelets, Agranulocytosis, Thrombocytopenia, Mouth ulceration, Stomatitis, Pneumonia, Sepsis, Angioedema, Urticaria, Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, Exfoliative rash, Exfoliative dermatitis, Stevens-Johnson syndrome, Toxic skin eruption, Toxicoderma"
145,VICTRELIS,warnings and precautions,"Embryofetal Toxicity, birth defects, fetal death, anemia, hemoglobin decrease, neutropenia, hypersensitivity, urticaria, angioedema, death"
146,VIMIZIM,adverse reactions,"Anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, death"
147,VIMIZIM,boxed warnings,"Anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, death"
148,VIMIZIM,warnings and precautions,"Anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, sleep apnea, airway patency, spinal cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, Nausea, Arthralgia, Headache, Hemoptysis, Chest Pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, Death"
150,SIRTURO,boxed warnings,"Increased Mortality, Death, QT Prolongation"
151,SIRTURO,warnings and precautions,"QT prolongation, Ventricular arrhythmia, Hepatotoxicity, Liver injury, Increased mortality (death), Torsade de Pointes, Congenital long QT syndrome, Hypothyroidism, Bradyarrhythmias, Heart failure, Hypokalemia, Hypocalcemia, Hypomagnesemia, Syncope, Hepatic-related adverse reactions, Alcohol-related adverse reactions, Fatigue, Anorexia, Nausea, Jaundice, Dark urine, Liver tenderness, Hepatomegaly, Aminotransferase elevations, Total bilirubin elevation, ALT elevation, AST elevation, Alkaline phosphatase elevation, Bilirubin elevation."
152,NEURACEQ,adverse reactions,"injection site reaction, erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, False positives, Errors in the estimation of brain neuritic beta-amyloid plaque density, Errors in cases with severe brain atrophy, Errors due to motion artifacts, Increased risk of cancer, Death"
154,COMETRIQ,adverse reactions,"Perforations, Fistula, Hemorrhage, Thromboembolic Events, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, diarrhea, stomatitis, palmar-plantar erythrodysesthesia syndrome, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, hypertension, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysphagia, dyspepsia, hemorrhoids, vomiting, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased TSH, malignant hypertension, death."
155,COMETRIQ,boxed warnings,"Perforations, Fistulas, Hemorrhage, Bleeding, Hemoptysis, Gastrointestinal hemorrhage, Death"
156,COMETRIQ,warnings and precautions,"Thrombotic Events, death, Wound Complications, Hypertension, Osteonecrosis of the Jaw, Palmar-plantar Erythrodysesthesia syndrome, Proteinuria, Reversible Posterior Leukoencephalopathy Syndrome, death, Gastrointestinal perforations, Fistulas, death, Hemorrhage, death."
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, death, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, anemia, decreased potassium, thrombocytopenia, infections, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, cough, epistaxis, pruritus, alopecia, hot flush, stomatitis, diarrhea, nausea, vomiting, constipation, dry mouth, fatigue, edema peripheral, pyrexia, asthenia, infections, weight decreased, decreased appetite, hyperglycemia, headache, dizziness, hypertension, irregular menstruation, decreased hemoglobin, hyperglycemia, alkaline phosphatase increased, bicarbonate decreased, hypercholesterolemia, neutropenia, hypophosphatemia, thrombotic events, pulmonary embolus, thrombosis, abdominal pain, dehydration, pneumonia, asthenia, anorexia, diabetes mellitus, arthralgia, pain in extremity, muscle spasms, dyspnea, cough, epistaxis, pneumonitis, rash, pruritus, dry skin, hypertension, jaw pain, hemorrhage, hypoglycemia, myocardial infarction, congestive heart failure, sudden death, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, renal failure, tachycardia, congestive cardiac failure, cellulitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"Non-infectious pneumonitis, death, infections, death, angioedema, oral ulceration, renal failure, death, impaired wound healing, laboratory test alterations, death, vaccinations, embryo-fetal toxicity, death"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, death, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, arthralgia, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness."
160,BREO,boxed warnings,"Asthma-related death, death, Increase in asthma-related deaths, Risk of asthma-related death, Increase in asthma-related hospitalization"
161,BREO,warnings and precautions,"Asthma-related death, death, Deterioration of Disease and Acute Episodes, Pneumonia, death, Immunosuppression, Impaired adrenal function, Hypercorticism and adrenal suppression, Paradoxical bronchospasm, death, Hypersensitivity reactions, including anaphylaxis, Cardiovascular effects, death, Reduction in bone mineral density, Glaucoma and cataracts, Coexisting conditions, Hypokalemia and hyperglycemia, Effect on growth"
162,FIRAZYR,adverse reactions,"Injection site reactions, death, Pyrexia, Transaminase increase, Dizziness, Rash, Nausea, Headache"
163,FIRAZYR,warnings and precautions,"Laryngeal attacks, Airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, death, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, death, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Loss of strength or energy (asthenia), Pancreatitis (acute or chronic), Hypersensitivity-related adverse reactions, Photosensitivity-related adverse reactions, Volume Depletion-Related Adverse Reactions, Falls, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C) and non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density"
165,INVOKANA,warnings and precautions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital mycotic infections, Hypersensitivity reactions, Bone fracture, Increased LDL-C"
166,VORAXAZE,adverse reactions,"anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, death"
167,VORAXAZE,warnings and precautions,"Serious allergic reactions, anaphylactic reactions, death"
168,NESINA,adverse reactions,"Nasopharyngitis, Headache, Upper Respiratory Tract Infection, Pancreatitis, Hypersensitivity Reactions (including anaphylaxis, angioedema, rash, urticaria, Stevens-Johnson syndrome), Hypoglycemia"
169,NESINA,warnings and precautions,"Acute pancreatitis, Hypersensitivity, Anaphylaxis, Angioedema, Severe cutaneous adverse reactions, Hepatic failure, Death, Hypoglycemia, Arthralgia, Severe joint pain, Macrovascular risk reduction"
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, Vascular Events, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, Lymphomas, death"
171,GILENYA,warnings and precautions,"Bradycardia, atrioventricular conduction, bradyarrhythmia, AV blocks, Infections, Progressive multifocal leukoencephalopathy (PML), Macular edema, Posterior reversible encephalopathy syndrome (PRES), Decrease in pulmonary function tests (PFT), Liver injury, Death (associated with herpetic infections), Cryptococcal infections, Hypotension, dizziness, fatigue, palpitations, chest pain, Herpes viral infections, Disseminated varicella zoster and herpes simplex infections, Cryptococcal meningitis, Hypertension, Immune system effects following GILENYA discontinuation"
172,HALAVEN,adverse reactions,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, death, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, alopecia, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus."
173,HALAVEN,warnings and precautions,"Neutropenia, Peripheral Neuropathy, Embryo-Fetal Toxicity, QT Prolongation"
174,INTELENCE,adverse reactions,"Severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, death"
175,INTELENCE,warnings and precautions,"Severe skin reactions, Potentially life-threatening skin reactions, Fatal skin reactions, Stevens-Johnson syndrome, Hypersensitivity reaction, Toxic epidermal necrolysis, Erythema multiforme, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), Rash, Constitutional findings, Organ dysfunction, Hepatic failure, Grade 3 and 4 rashes, Rash with systemic symptoms, Liver transaminase elevations, Rash accompanied by fever, General malaise, Fatigue, Muscle or joint aches, Blisters, Oral lesions, Conjunctivitis, Facial edema, Hepatitis, Eosinophilia, Angioedema, Death"
176,AMYVID,adverse reactions,"Headache, Musculoskeletal pain, Blood pressure increased, Nausea, Fatigue, Injection site reaction, Anxiety, Back pain, Claustrophobia, Dizziness, Feeling cold, Insomnia, Neck pain, Infusion site rash, Dysgeusia, Pruritis, Urticaria, Flushing"
177,AMYVID,warnings and precautions,"Image interpretation errors, Radiation risk, Errors in Amyvid estimation of brain neuritic plaque density, Extensive brain atrophy, Motion artifacts, Increased risk of cancer"
178,ULESFIA,adverse reactions,"Ocular irritation, eye irritation, Application site irritation, skin irritation, scalp irritation, Application site anesthesia, hypoesthesia, Pain, Pruritus, itching, Erythema, redness, Pyoderma, Dryness, Excoriation, Paraesthesia, Dermatitis, Thermal burn, Dandruff, Rash, Skin exfoliation"
179,ULESFIA,warnings and precautions,"Neonatal toxicity, death, Eye irritation, Contact dermatitis"
180,OTEZLA,adverse reactions,"Diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, death"
181,OTEZLA,warnings and precautions,"Depression, Suicidal thoughts, Mood changes, Weight decrease, Weight loss, Drug interactions, Suicide"
182,ILARIS,adverse reactions,"nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, infections, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, hypersensitivity, white blood cells decrease, neutrophils decrease, platelets decrease, transaminases elevation, bilirubin elevation, death"
183,ILARIS,warnings and precautions,"Serious Infections, upper respiratory tract infections, unusual or opportunistic infections (e.g., aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster), tuberculosis, reactivation of latent tuberculosis, opportunistic infections, infections, serious infections, death, Immunosuppression, malignancies, Hypersensitivity reactions, anaphylactic reactions, Macrophage Activation Syndrome"
184,NATAZIA,adverse reactions,"Serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraines, pain, menstrual disorders, vomiting, acne, mood changes, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis."
185,NATAZIA,boxed warnings,"Serious cardiovascular events, Cardiovascular events, death"
186,NATAZIA,warnings and precautions,"Thrombotic event, Vascular risks, Thromboembolic Disorders, Vascular Problems, Venous thromboembolism, Arterial thrombotic event, VTE, Venous thromboembolism, Arterial thromboses, Strokes, Myocardial infarctions, Thromboembolic disease, Cerebrovascular events, Stroke, Carcinoma of the Breasts, Reproductive Organs, Breast cancer, Cervical cancer, Intraepithelial neoplasia, Liver disease, Jaundice, Hepatic adenomas, Hepatocellular carcinoma, Liver cancers, Gallbladder Disease, Carbohydrate metabolic effects, Lipid metabolic effects, Prediabetic, Diabetic, Dyslipidemia, Hypertriglyceridemia, Pancreatitis, Headache, Migraine, Bleeding Irregularities, Breakthrough bleeding, Spotting, Amenorrhea, Intracyclic bleeding, Depression, Interference with Laboratory Tests, Drug Interactions, CYP3A4 induction, Hereditary angioedema, Chloasma, Death."
187,DIFICID,adverse reactions,"Nausea, Vomiting, Abdominal pain, Gastrointestinal hemorrhage, Anemia, Neutropenia, Death"
188,DIFICID,warnings and precautions,"Acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior, Ideation, Constipation, Pyrexia, Lethargy, Drooling, Death"
190,ONFI,warnings and precautions,"Somnolence, Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Physical and Psychological Dependence, Suicidal Behavior, Suicidal Ideation, Death"
191,TECFIDERA,adverse reactions,"Anaphylaxis, Angioedema, Progressive multifocal leukoencephalopathy, Lymphopenia, Flushing, Abdominal pain, Diarrhea, Nausea, Vomiting, Pruritus, Rash, Albumin urine present, Erythema, Dyspepsia, Aspartate aminotransferase increased, Gastrointestinal events, Hepatic Transaminases, Eosinophilia"
192,TECFIDERA,warnings and precautions,"Anaphylaxis, angioedema, death, Progressive Multifocal Leukoencephalopathy, PML, lymphopenia, Flushing"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, feeling abnormal, breathing difficulties, dyspnea, blurred vision, diplopia, reduced visual acuity, accommodation, muscle atrophy, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site discomfort, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, hypertonia, sensation of heaviness, antibody formation, binding antibodies, neutralizing antibodies."
194,DYSPORT,boxed warnings,"Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphagia, Dysphonia, Dysarthria, Urinary incontinence, Breathing difficulties, Death"
195,DYSPORT,warnings and precautions,"Dysphagia, Swallowing difficulties, Breathing difficulties, Speech difficulties, Asthenia, Generalized muscle weakness, Diplopia, Blurred vision, Ptosis, Dysphonia, Dysarthria, Urinary incontinence, Respiratory failure, Death"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, myopathy, rhabdomyolysis, non-infectious pneumonitis, insomnia, groin pain, constipation, pyrexia, falls, hematuria, rash, nasopharyngitis, hypernatremia, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, sudden death, death."
197,ZYTIGA,warnings and precautions,"hypertension, hypokalemia, fluid retention, edema, adrenocortical insufficiency, hepatotoxicity, death"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, Muscle spasms, Nausea, Diarrhea, Dyspepsia, Abdominal pain upper, Oropharyngeal pain, Dizziness, Neck pain, Venous thromboembolism, Death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis, dementia, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain, death"
200,DUAVEE,warnings and precautions,"Cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, stroke, coronary heart disease, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, retinal vascular thrombosis, elevated blood pressure, hypertriglyceridemia, hepatic impairment, cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, exacerbation of angioedema, impaired glucose tolerance, death."
201,SAPHRIS,adverse reactions,"Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Akathisia, Oral Hypoesthesia, Somnolence, Dizziness, Extrapyramidal symptoms, Increased weight, Dysgeusia, Oral Paresthesia, Nausea, Increased appetite, Fatigue, Akathisia and hyperkinesia, Dystonia, Oculogyration, Muscle rigidity, Parkinsonism, Tremor, Extrapyramidal disorder, Constipation, Dry mouth, Salivary hypersecretion, Stomach discomfort, Vomiting, Fatigue, Irritability, Increased weight, Increased appetite, Arthralgia, Pain in extremity, Headache, Insomnia, Hypertension, Anxiety, Depression, Anger, Dysmenorrhea, Oropharyngeal pain, Nasal congestion, Dyspnea, Rash, Edema peripheral, Dyspepsia, Increased weight, Somnolence, Dizziness, Insomnia, Suicidal ideation, Oral hypoesthesia, Fatigue, Irritability, Muscle strain, Increased weight, Hyperinsulinemia, ALT increased, AST increased, Myalgia, Somnolence, Headache, Dizziness, Dysgeusia, Akathisia, Parkinsonism, Insomnia, Suicidal ideation, Anger, Dysmenorrhea, Oropharyngeal pain, Nasal congestion, Dyspnea, Rash, Choking, Oropharyngeal muscular dysfunction, Hypoesthesia"
202,SAPHRIS,boxed warnings,"Increased mortality, Death"
203,SAPHRIS,warnings and precautions,"Cerebrovascular Adverse Events, Stroke, Transient Ischemic Attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Anaphylaxis, Angioedema, Orthostatic Hypotension, Syncope, Dizziness, Tachycardia, Bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive Impairment, Motor Impairment, Suicide, Death, Dysphagia, Aspiration pneumonia, Hyperprolactinemia."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex infection, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, conjunctival hyperemia, dry eye, iridocyclitis, death."
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity and fields of vision, Cataracts, posterior subcapsular cataract formation, Delayed healing, bleb formation, corneal thinning, scleral thinning, perforations, Bacterial infections, suppression of host response, secondary ocular infections, masking of infection, enhanced existing infection, Viral infections, exacerbation of viral infections, herpes simplex caution, Fungal infections, corneal fungal infections, fungus invasion, Death."
206,ZYDELIG,adverse reactions,"Hepatotoxicity, liver damage, Severe Diarrhea, severe colitis, Pneumonitis, lung inflammation, Intestinal Perforation, bowel perforation, Severe Cutaneous Reactions, severe skin reactions, Anaphylaxis, severe allergic reaction, Neutropenia, low white blood cell count, Diarrhea, colitis, Pyrexia, fever, Fatigue, Nausea, Cough, Pneumonia, Abdominal pain, Chills, Rash, Sepsis, severe infection, Febrile neutropenia, fever with low white blood cell count, Elevated transaminases, liver enzyme elevation, Gastroesophageal reflux disease, Stomatitis, mouth inflammation, Headache, Vomiting, Nasal congestion, Bronchitis, Sinusitis, Urinary tract infection, Arthralgia, joint pain, Pain, Rash, Insomnia, Peripheral edema, Dyspnea, difficulty breathing, Night sweats, Asthenia, weakness, Decreased appetite, Upper respiratory tract infection, Hemoglobin decreased, Platelets decreased"
207,ZYDELIG,boxed warnings,"Hepatic toxicity, Severe diarrhea, Colitis, Pneumonitis, Intestinal perforation, Death"
208,ZYDELIG,warnings and precautions,"Severe cutaneous reactions, toxic epidermal necrolysis, dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, anaphylaxis, neutropenia, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death."
209,KALBITOR,adverse reactions,"Hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, upper respiratory tract infection, death"
210,KALBITOR,boxed warnings,"Anaphylaxis, Hypersensitivity reactions, Death"
211,KALBITOR,warnings and precautions,"Hypersensitivity reactions, Anaphylaxis, Chest discomfort, Flushing, Pharyngeal edema, Pruritus, Rash, Rhinorrhea, Sneezing, Nasal congestion, Throat irritation, Urticaria, Wheezing, Hypotension, Death"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Increased Toxicity in the Presence of Severe Renal Impairment, Increased Toxicity in the Presence of Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy, Pulmonary Toxicity, Serious Dermatologic Reactions, Death"
213,ADCETRIS,boxed warnings,"Progressive multifocal leukoencephalopathy (PML), JC virus infection, Death"
214,ADCETRIS,warnings and precautions,"Peripheral neuropathy, neuropathy, sensory neuropathy, motor neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, hepatocellular injury, transaminases elevation, bilirubin elevation, progressive multifocal leukoencephalopathy, JC virus infection, PML, pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations, death."
215,BESIVANCE,adverse reactions,"Conjunctival redness, eye redness, Blurred vision, Eye pain, Eye irritation, Eye pruritus, itchy eyes, Headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms, Overgrowth of non-susceptible organisms, Fungal overgrowth, Super-infection, Signs or symptoms of bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, death"
218,CLEVIPREX,warnings and precautions,"Hypotension, Reflex tachycardia, Systemic hypotension, Negative inotropic effects, Exacerbate heart failure, Rebound hypertension"
219,XTANDI,adverse reactions,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, dyspnea, exertional dyspnea, dyspnea at rest, nasopharyngitis, sinusitis, rhinitis, pharyngitis, laryngitis, pneumonia, bronchitis, lung infection, neutropenia, thrombocytopenia, ALT elevations, bilirubin elevations, infections, sepsis, falls, fall-related injuries, joint injuries, hematomas, non-pathologic fractures, hypertensive crisis, hypertension."
220,XTANDI,warnings and precautions,"Seizure, death"
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Death, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Platelet count low, Absolute neutrophil count low, Hemoglobin low, SGPT/ALT high, SGOT/AST high, Lipase high, Phosphorus low, Total bilirubin high, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Pain, Hepatotoxicity, Abnormal hepatic function, Liver injury, Drug hypersensitivity, Pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption."
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, nausea, vomiting, abdominal pain, Myelosuppression, Thrombocytopenia, anemia, neutropenia, Hepatic Toxicity, ALT elevation, AST elevation, Fluid Retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, Renal Toxicity, decline in estimated glomerular filtration rate, Embryofetal Toxicity, fetal harm, death"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash."
224,CARBAGLU,warnings and precautions,"Hyperammonemia, Elevated plasma ammonia levels, Brain injury, Brain damage, Death"
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, death, Upper respiratory tract infection, Viral infection, Bronchitis, Hypertension, Rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, infusion reactions, immunogenicity, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Dizziness, paresthesia, Constipation, Melanoma, Serious systemic hypersensitivity reactions, sarcoidosis, Interstitial lung disease, Skin exfoliation, bullous skin reactions."
226,SIMPONI,boxed warnings,"Serious infections, hospitalization, death, tuberculosis, bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, lymphoma, malignancies"
227,SIMPONI,warnings and precautions,"Serious infections, death, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, exacerbation, new onset, hypersensitivity reactions, anaphylaxis"
228,BENLYSTA,adverse reactions,"Mortality, death, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, viral gastroenteritis, fatal anaphylaxis"
229,BENLYSTA,warnings and precautions,"Mortality, death, Serious Infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), fatal cases, Malignancy, Hypersensitivity Reactions, Anaphylaxis, death, Depression, suicidality, Immunization, Infusion Reactions."
230,TOVIAZ,adverse reactions,"dry mouth, constipation, angina, chest pain, gastroenteritis, QT prolongation on ECG, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, urinary retention, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, death"
231,TOVIAZ,warnings and precautions,"Angioedema, face swelling, lip swelling, tongue swelling, larynx swelling, urinary retention, gastrointestinal motility decrease, constipation, narrow-angle glaucoma, somnolence, central nervous system effects, headache, dizziness, myasthenia gravis, death"
232,ENTEREG,adverse reactions,"The adverse reactions mentioned in the text are dyspepsia. Since no fatal events are listed, 'death' is not added to the list. Therefore, the adverse reactions extracted from the text are: dyspepsia."
233,ENTEREG,boxed warnings,"Myocardial infarction, Heart attack, Death"
234,ENTEREG,warnings and precautions,"Myocardial infarctions, death, abdominal pain, nausea, vomiting, diarrhea, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, surgery, pancreatic anastomosis, gastric anastomosis"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"Hypersensitivity reactions, flushing, dyspnea, Image interpretation errors, false positives, Radiation risk"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, Urinary tract infection, Insomnia, Dizziness, Headache, Nausea, Asthenia, Back pain, Balance disorder, Multiple sclerosis relapse, Paresthesia, Nasopharyngitis, Constipation, Dyspepsia, Pharyngolaryngeal pain, Death"
238,AMPYRA,warnings and precautions,"Seizures, death, anaphylaxis"
